|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S3
|
$600,000
|
$18,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S4
|
$75,000
|
$2,250
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
2R01CA044722-22A1
|
$202,321
|
$101,161
|
Studzinski, George
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
|
Validation of microRNAs as therapeutic targets in hematological malignancies
|
5R01CA135332-02
|
$316,438
|
$158,219
|
MARCUCCI, GUIDO
|
OHIO STATE UNIVERSITY
|
|
Validating a novel biomarker of clinical progression and survival in CLL
|
5R33CA161731-02
|
$400,042
|
$400,042
|
DAVIS, RANDALL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S3
|
$4,555,705
|
$91,114
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S4
|
$74,854
|
$1,497
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S5
|
$139,989
|
$2,800
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S1
|
$50,000
|
$500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S2
|
$246,000
|
$2,460
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S3
|
$74,999
|
$750
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-37
|
$6,285,726
|
$62,857
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
5P50CA100632-10
|
$2,300,000
|
$1,173,000
|
Kantarjian, Hagop
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Hawaii Cancer Center CCSG
|
2P30CA071789-13
|
$1,150,000
|
$23,000
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Understanding Hemotopoietic Neoplasias using Humanized Mice
|
5R01CA156689-03
|
$489,981
|
$489,981
|
FLAVELL, RICHARD
|
YALE UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-13S1
|
$74,459
|
$745
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-13
|
$2,947,311
|
$29,473
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Investigation of KRas & NF1 in Myeloid Leukemia
|
4R37CA072614-16
|
$320,588
|
$320,588
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
Transcription Factor Regulation by the BCR/ABL Oncogene
|
5R01CA095111-09
|
$301,843
|
$150,922
|
CALABRETTA, BRUNO
|
THOMAS JEFFERSON UNIVERSITY
|
|
TOWARD AN UNDERSTANDING OF CLL PROGRESSION
|
5R01CA151319-02
|
$375,020
|
$375,020
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
The UT MD Anderson Cancer Center Community Clinical Oncology Program Research Bas
|
2U10CA045809-24
|
$1,389,595
|
$83,376
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Therapy of CML
|
5P01CA049639-22
|
$3,537,028
|
$3,537,028
|
CHAMPLIN, RICHARD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Role of the APC Tumor Suppressor Gene in Hematopoiesis and Leukemogenesis
|
5R01CA140979-03
|
$325,775
|
$325,775
|
QIAN, ZHIJIAN
|
UNIVERSITY OF ILLINOIS
|
|
The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission)
|
1R01CA160433-01A1
|
$336,150
|
$336,150
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
|
The Role of Oncogenic Ras in Leukemogenesis and Response to Targeted Therapies
|
5K08CA134649-05
|
$127,170
|
$63,585
|
Li, Qing
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The role of Hedgehog in hematopoiesis and leukemogenesis
|
5K08CA140723-03
|
$164,250
|
$82,125
|
Hofmann Zhang, Inga
|
CHILDREN'S HOSPITAL BOSTON
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S3
|
$4,829,857
|
$193,194
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S4
|
$75,000
|
$3,000
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S5
|
$76,389
|
$3,056
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Impact of Hspa9 Haploinsufficiency on Murine Hematopoiesis and Leukemogenesis
|
1F31CA165702-01A1
|
$28,427
|
$28,427
|
Krysiak, Kilannin
|
WASHINGTON UNIVERSITY
|
|
Targeting PML for therapy in leukemia-initiating cells
|
4R00CA139009-03
|
$249,000
|
$249,000
|
ITO, KEISUKE
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Targeting PML for leukemia therapy.
|
5R01CA142874-03
|
$455,022
|
$455,022
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting Leukemic Stem Cells
|
5R01CA138211-05
|
$418,058
|
$209,029
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
5R01CA157537-02
|
$317,475
|
$317,475
|
PANG, QISHEN
|
CHILDREN'S HOSPITAL MEDICAL CENTER CINCI
|
|
T cell repertoire of graft-versus-host disease and graft-versus-tumor effects
|
5R01CA154244-08
|
$388,635
|
$388,635
|
Friedman, Thea
|
HACKENSACK UNIVERSITY MEDICAL CENTER
|
|
Systems Biology of Diversity in Cancer
|
5U54CA148967-03
|
$2,729,985
|
$300,298
|
SANDER, CHRIS
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
SunCoast CCOP Research Base at the University of South Florida
|
5U10CA081920-11
|
$1,830,654
|
$54,920
|
KRISCHER, JEFFREY
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIABC010782
|
$343,957
|
$85,989
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Studies of BCR-ABL leukemogenesis in mice
|
2R01CA090576-12
|
$304,498
|
$304,498
|
Van Etten, Richard
|
TUFTS MEDICAL CENTER
|
|
Stanford University Cancer Center
|
3P30CA124435-06S1
|
$74,997
|
$750
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Stanford University Cancer Center
|
5P30CA124435-06
|
$3,091,618
|
$30,916
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Sapacitabine therapy to create synthetic lethality in DNA repair-deficient CLL
|
1R01CA163802-01A1
|
$327,850
|
$327,850
|
WIERDA, WILLIAM
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Roswell Park Cancer Institute Center Support Grant
|
3P30CA016056-36S1
|
$107,301
|
$2,146
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Center Support Grant
|
3P30CA016056-36S2
|
$140,000
|
$2,800
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Center Support Grant
|
3P30CA016056-36S3
|
$75,000
|
$1,500
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Center Support Grant
|
5P30CA016056-36
|
$3,960,459
|
$79,209
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roles of the Fanconi Anemia Pathway in Bladder Tumorigenesis
|
5R01CA136532-05
|
$301,913
|
$301,913
|
FEI, PEIWEN
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Roles of SIRT1 in normal hematopoietic and leukemic stem cells
|
5R01CA143421-02
|
$313,740
|
$313,740
|
CHEN, WENYONG
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Role of TET proteins in myeloid malignancies
|
1R01CA151535-01A1
|
$370,180
|
$370,180
|
Rao, Anjana
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
|
Role of Shp2 in FLT3-ITD-Induced Leukemogenesis
|
5R01CA134777-02
|
$319,550
|
$319,550
|
CHAN, REBECCA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $39,373,913
|